The clinical-stage healthcare company, Kaleido Biosciences Inc. (KLDO) announced ceasing operations altogether on Friday. The company’s SEC filing revealed plans to wind down operations, total staff lay-off, and voluntary Nasdaq delisting. Thus, currently, the investors are trying to make some final profit from KLDO stock before the wind down by the end of the month. […]
On April 12, Alzamend Neuro Inc. (ALZN) rebounded in the after-hours following a decline of 2.86% in regular trading. Thus, ALZN was trading at a price of $1.20 per share against its previous close of $1.02. A day before, the company shared news of two new contracts for managing and conducting its Alzheimer’s study. Following
Alzamend Neuro Inc. (ALZN) stock Rebounds After Hours. What Happened? Read More »
Shares of Histogen Inc. (HSTO) exploded on April 12, during the regular trading session. The stock peaked at $0.4161 to add 67.78% at the close of the session. This rally was then followed by corrections in the after-hours as HSTO fell by 4.35%. Thus, the stock was then trading at a value of $0.3980 per
Histogen Inc. (HSTO)’s Upsurge Culminates in Corrections After Hours Read More »
The long-beaten down transdermal patch developer, Agile Therapeutics Inc. (AGRX) made its comeback on Tuesday. Having bounced back on April 12, the stock rallied in both the regular and after-hours sessions with gains of 47.18% and 27.74% respectively. Thus, after spiking up to $0.1878 in regular trading, AGRX reached $0.2399 in the after hours. There
Agile Therapeutics Inc. (AGRX) stock Continues its Rally on Rebound Energy Read More »
On April 12, Lixte Biotechnology Holdings Inc. (LIXT) came out with a couple of pieces of news that made the stock move up and down. The latest news from the company was a registered direct offering priced At-The-Market. This caused the stock to plunge down to $1.66 in the after-hours with a loss of 9.78%.
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.